The Global Artificial Intelligence in Clinical Trials Market Size is growing at a CAGR of 12% by 2032, estimates DelveInsight

DelveInsight's Artificial Intelligence in Clinical Trials Market Insights Report 2032 provides the current and forecast market analysis, individual leading Artificial Intelligence in Clinical Trials Companies market shares, challenges, Artificial Intelligence in Clinical Trials Market Drivers, barriers, trends, and key market Artificial Intelligence in Clinical Trials companies in the market.

To read more about the latest highlights related to the Artificial Intelligence in Clinical Trials Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/ai-in-clinical-trials-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Artificial Intelligence in Clinical Trials Market Report
• In May 2025, Avant Technologies, Inc. (OTCQB: AVAI) and JV partner Ainnova Tech, Inc. announced they had begun acquisition talks to strengthen their position in the evolving AI-driven healthcare market.
• In March 2025, Suvoda has launched Sofia, an AI-powered assistant designed to streamline clinical trial management. Built to support study teams, Sofia simplifies access to and review of critical trial information by delivering intelligent, real-time insights. This innovation enhances operational efficiency, reduces manual workload, and empowers teams to make faster, data-driven decisions throughout the trial lifecycle.
• The Artificial Intelligence in clinical trials market was valued at USD 1,350.79 million in 2024, growing at a CAGR of 12.04 % during the forecast period from 2025 to 2032 to reach USD 3,334.47 million by 2032
• The leading Artificial Intelligence in Clinical Trials Companies such as TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, and others.
• North America is projected to hold the largest share of the Artificial Intelligence in Clinical Trials market in 2024, driven by several key factors.

To know more about why North America is leading the market growth in the Artificial Intelligence in Clinical Trials Market, get a snapshot @ Artificial Intelligence in Clinical Trials Market Outlook- https://www.delveinsight.com/sample-request/ai-in-clinical-trials-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Artificial Intelligence in Clinical Trials Market Dynamics
The growing prevalence of chronic diseases is expected to drive AI in clinical trial market growth. For instance, according to GLOBOCAN data from 2023, approximately 20 million new cancer cases were reported in 2022, with this number projected to rise to 32.6 million by 2045 around the world. As per the data from the World Health Organization (WHO) 2024, in the Eastern Mediterranean Region, over 788,000 cancer diagnoses were recorded in 2022. This figure is anticipated to double to approximately 1.57 million cases by 2045. According to data published by the British Heart Foundation 2024, approximately 640 million people globally were affected by heart and circulatory diseases, with these numbers anticipated to rise in the coming years. The same source notes that around 67 million individuals are diagnosed with heart or circulatory diseases each year.

Artificial Intelligence in Clinical Trials Market Segmentation Analysis
AI in Clinical Trials Market by Product (Software and Services), Technology (Machine Learning (ML), Natural Language Processing (NLP), and Others), Application (Clinical Trial Design & Optimization, Patient Identification & Recruitment, Site Identification & Trial Monitoring, and Others), Therapeutic Area (Oncology, Cardiology, Neurology, Infectious Disease, Immunology, and Others), End-User (Pharmaceutical & Biotechnology Companies and Medical Device Companies), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Get a sneak peek at the Artificial Intelligence in Clinical Trials Market Dynamics @ Artificial Intelligence in Clinical Trials Market Dynamics Analysis- https://www.delveinsight.com/sample-request/ai-in-clinical-trials-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Artificial Intelligence in Clinical Trials Companies
TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, and others.

Artificial Intelligence in Clinical Trials Market Drivers
The AI in Clinical Trials market is driven by the increasing global burden of chronic diseases such as diabetes, cardiovascular conditions, respiratory disorders, and cancer. This surge is further supported by rising investments and funding aimed at advancing drug discovery and development processes. Moreover, the growing trend of strategic collaborations and partnerships among pharmaceutical, biotechnology, and medical device companies is playing a crucial role in accelerating the adoption of AI-powered clinical trial solutions.

Which MedTech key players in the Artificial Intelligence in Clinical Trials Market are set to emerge as the trendsetter explore @ Artificial Intelligence in Clinical Trials Companies- https://www.delveinsight.com/sample-request/ai-in-clinical-trials-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Artificial Intelligence in Clinical Trials Market Report
• Coverage- Global
• Forecast Period- 2025-2032
• Artificial Intelligence in Clinical Trials Companies- TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, and others.

Interested in knowing the Artificial Intelligence in Clinical Trials Market by 2032? Click to get a snapshot of the Artificial Intelligence in Clinical Trials Market Trends- https://www.delveinsight.com/sample-request/ai-in-clinical-trials-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Artificial Intelligence in Clinical Trials Market Report Introduction
2. Artificial Intelligence in Clinical Trials Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Artificial Intelligence in Clinical Trials Market Key Factors Analysis
6. Artificial Intelligence in Clinical Trials Market Porter's Five Forces Analysis
7. Artificial Intelligence in Clinical Trials Market Assessment
8. Artificial Intelligence in Clinical Trials Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

About Us

DelveInsight is a leading focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and pharma sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.